CELANESE CORPORATION
Celanese Corporation (CE)
Overview
Celanese Corporation is a global specialty materials and chemicals company headquartered in Irving, Texas, operating 51 production facilities worldwide with approximately 11,434 employees as of December 31, 2025. Celanese makes engineered polymers used in automotive, medical, electronics, and industrial applications, and it separately runs one of the world's largest integrated "acetyl chain" businesses producing acetic acid, vinyl acetate monomer, and related downstream chemicals used in paints, adhesives, and packaging. Fiscal 2025 was a difficult year: revenue fell about 7% year over year to $9.54 billion and the company swung to a net loss of $1.17 billion, reflecting weak demand in key end markets (particularly automotive and construction-linked chemicals), pricing pressure in commodity-adjacent acetyl products, and a heavy debt load taken on to fund its 2022 acquisition of DuPont's Mobility & Materials business. Trailing-twelve-month revenue as of mid-2026 stood at roughly $9.71 billion, still down from prior-year levels, and the stock trades well below its historical highs even as analysts note deep value if margins recover.
What They Do & How They Make Money
Celanese earns money two distinct ways. In Engineered Materials, it sells specialty polymer compounds — nylons, polyoxymethylene (POM), liquid crystal polymers, long-fiber reinforced thermoplastics, and thermoplastic elastomers — under brands including Celanyl, Zytel, Celcon, Hostaform, Vectra, Zenite, Celstran, Hytrel, and Santoprene. This is a project-based, engineering-intensive business: Celanese works directly with automotive OEMs, medical-device makers, and electronics manufacturers to get its materials designed into specific parts (fuel systems, connectors, battery separators using its GUR ultra-high-molecular-weight polyethylene), which supports better margins than commodity plastics. In the Acetyl Chain, Celanese runs vertically integrated plants that convert methanol and other feedstocks into acetic acid and acetic anhydride, then further into vinyl acetate monomer, emulsion polymers (EcoVAE, Mowilith, Vinamul) for water-based paints, ethylene vinyl acetate resins (Ateva) for flexible packaging, and acetate tow for cigarette filters. Proprietary process technology (AOPlus 3, VAntage 2) is meant to keep per-unit production costs low across this chain. Celanese also holds stakes in 18 strategic ventures/joint ventures — including 50%-owned Fortron Industries (polyphenylene sulfide), Korea Engineering Plastics, and Fairway Methanol — which together generated $1.9 billion of sales and $78 million of equity earnings for Celanese in 2025.
Business Segments
- Engineered Materials — Specialty polymer compounds sold into automotive, medical, electronics, and industrial end markets, emphasizing customer co-development and application-specific formulations rather than commodity resin sales.
- Acetyl Chain — Integrated production of acetic acid, vinyl acetate monomer, emulsion polymers, EVA resins, redispersible powders, and acetate tow, serving paints, adhesives, construction, pharmaceutical, and packaging customers globally from facilities across North America, Europe, and Asia.
Competitive Landscape
Celanese's 2025 10-K does not name specific competitors in Item 1, but the company competes broadly against other large specialty-chemicals and engineered-plastics producers (peers of this scale include Eastman Chemical, BASF, Dow, DuPont, and various Asian acetyls producers) as well as smaller regional compounders. Competition centers on production cost (especially in the more commodity-like acetyl chain, where Chinese capacity additions have pressured global pricing), application engineering and technical service (in Engineered Materials, where being designed into a customer's part creates switching friction), and breadth of product portfolio that lets Celanese serve a customer across multiple material types from one supplier relationship.
Financial Overview
| Metric | FY2025 | TTM (mid-2026) |
|---|---|---|
| Revenue | $9.54B | $9.71B |
| Revenue growth | -7.05% YoY | still declining |
| Gross margin | ~20.6% | ~21.4% |
| Operating margin | ~8.7% | ~9.5% |
| Net income | -$1.17B | -$1.17B |
Strategic Strengths & Risks
Celanese's strength is the combination of an engineering-intensive, higher-margin specialty polymers business with a large-scale, cost-advantaged commodity-chemicals engine that funds R&D and gives it purchasing/logistics scale few peers can match. The acetyl chain's integration and proprietary process technology provide real cost advantages versus non-integrated producers. The risks are equally real: the acetyl chain is exposed to global oversupply and price competition (notably from Chinese producers), Engineered Materials volumes track cyclical end markets like auto production and construction, and the balance sheet carries substantial leverage from the 2022 DuPont M&M acquisition, which has amplified the impact of 2025's earnings decline into a large net loss. Recovery depends on end-market demand improving, acetyl pricing stabilizing, and continued deleveraging.